Plexus (PLXS)
(Delayed Data from NSDQ)
$117.71 USD
-6.82 (-5.48%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $116.97 -0.74 (-0.63%) 7:14 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$117.71 USD
-6.82 (-5.48%)
Updated Aug 2, 2024 04:00 PM ET
After-Market: $116.97 -0.74 (-0.63%) 7:14 PM ET
3-Hold of 5 3
B Value A Growth A Momentum A VGM
Zacks News
Electronics to Maintain Solid Momentum in 2020: 5 Stocks to Buy
by Shilpa Mete
Here we recommend five electronics stocks that are well-poised to sustain momentum in 2020 owing to growing proliferation of electronics across every major sector.
5 Top Notch Technology Stocks Set to Beat Nasdaq in 2020
by Shalu Saraf
Here we pick five technology stocks that are set to outperform Nasdaq in 2020.
Jabil (JBL) Looks Good: Stock Adds 6.9% in Session
by Zacks Equity Research
Jabil (JBL) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
5 Technology Stocks That Have Crushed Nasdaq in 2019
by Radhika Pujara
Here we pick five technology stocks that have outperformed Nasdaq in 2019.
6 Tech Stocks That Have Crushed FAANG in 2019
by Aniruddha Ganguly
Here we pick six stocks that have outperformed the FAANG group on a year-to-date basis in 2019.
The Zacks Analyst Blog Highlights: Ultra Clean Holdings, Plexus, Tennant, Cohu and Kaman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Ultra Clean Holdings, Plexus, Tennant, Cohu and Kaman
5 Top-Ranked Manufacturing Stocks to Buy Amid Slowdown in 2019
by Nalak Das
Despite slowdown, a few manufacturing stocks popped in the past six months and still have upside left.
Plexus (PLXS) Up 7.6% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Unifi, BioDelivery Sciences International, Crocs, Anika Therapeutics and Plexus
5 Top Momentum Stocks in October That Still Have Upside Left
by Nalak Das
Possibility of at least an interim trade deal between the largest trading countries of the world boosted investors' confidence on risky assets like equities.
Plexus Corp. (PLXS) Shares March Higher, Can It Continue?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor in Plexus Corp. (PLXS).
Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial
by Zacks Equity Research
Zacks.com featured highlights include: Plexus, Costamare, United Therapeutics, Intel and First American Financial
Top Ranked Momentum Stocks to Buy for October 30th
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 30th
5 Solid Relative Price Strength Stocks to Make You Rich
by Nilanjan Choudhury
Want to try an out-of-the-box approach to earn handsome returns? Tap these stocks with explosive relative price strength.
Plexus (PLXS) Q4 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) fourth-quarter results reflect robust revenues from Healthcare/Life Sciences, Industrial/Commercial and Aerospace/Defense sectors.
Plexus (PLXS) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of 8.14% and 4.12%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Earnings Preview: Plexus (PLXS) Q4 Earnings Expected to Decline
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Down 0.2% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q3 Earnings Miss Estimates, Revenues Up Y/Y
by Zacks Equity Research
Plexus' (PLXS) third-quarter results benefit from robust revenues from Healthcare/Life Sciences and Aerospace/Defense sectors despite unfavorable mix, which hurt margins.
Plexus (PLXS) Q3 Earnings Miss Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of -1.22% and 2.49%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Plexus (PLXS) Down 6.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Plexus (PLXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Plexus (PLXS) Q2 Earnings Miss Estimates, Revenues Beat
by Zacks Equity Research
Plexus (PLXS) second-quarter fiscal 2019 results benefit from strong performance of Healthcare/Life Sciences and Aerospace/Defense segments.
Plexus (PLXS) Q2 Earnings Miss Estimates
by Zacks Equity Research
Plexus (PLXS) delivered earnings and revenue surprises of -7.06% and 1.51%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Plexus (PLXS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Plexus (PLXS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.